Cyprotex

Activities: Regulatory

Trending Articles

  1. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  4. Dickson achieves ISO 14001 certification ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
  5. The key role of IVDs in healthcare: challenges to commercialisation and access In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and...

Upcoming event

Interphex

16-18 April 2024 | Conference and Exhibition | New York, US See all

Related Content

Analysis

Cyprotex expands its bioanalytical capabilities

To meet the requirements of existing and potential new customers
Research & Development

Cyprotex acquires CeeTox

Broadens toxicological assay and screening capabilities
Research & Development

Cyprotex to expand its UK facility into BioHub at Alderley Park

Will provide additional capacity for laboratories and office space
Research & Development

Cyprotex reports good performance across all parts of the business in first half

Gains new investors and raises £7m in cash to be used for further investment in the US and to assist with acquisitions
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Interview: Medicines and meteorites

ADME-Tox, good quality medicines and meteorites are three things that Tony Baxter, CEO of Cyprotex in Macclesfield, UK and Boston, US is keen on. He tells Jane Ellis why
Manufacturing

Cyprotex wins US government contract

Will provide high content imaging analysis for EPA ToxCast Project
Research & Development

Cyprotex launches eCiphrCardio cardiotoxicity service

To assess compounds in early drug development
Subscribe now